Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography

Vaccine

Volumn 16, Issue 2-3, 1998, Pages 119-129

  Richieri, Steven P ^a   Bartholomew, Richard ^a   Aloia, Roland C ^b,c   Savary, Jay ^a   Gore, Richard ^a   Holt, John ^a   Ferre, Francois ^a   Musil, Roy ^a   Tian, H R ^b,c   Trauger, Richard ^a   Lowry, Peter ^a   Jensen, Fred ^a   Carlo, Dennis J ^a   Maigetter, Robert Z ^a   Prior, Christopher P ^a  

^a Immune Response Corporation   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anion exchange purified; gp120 depleted; Human immunodeficiency virus (HIV 1); Protein, lipid, carbohydrate and RNA composition

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VIRUS VACCINE;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME IMMUNOASSAY; GEL FILTRATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; LIPID COMPOSITION; MOLECULAR WEIGHT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS PARTICLE;

CARBOHYDRATES; CHROMATOGRAPHY, ION EXCHANGE; HIV ENVELOPE PROTEIN GP120; HIV-1; LIPIDS; VIRAL PROTEINS; VIRION;

EID: 0031986075     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00196-5     Document Type: Article

References (26)

1. 1 Prior, C., Bay, P, and Ebert, B. et al. Process development for the manufacture of inactivated HIV-1. Biopharm. 1995, 4, 25-35.
2. 2 Prior, C., Gore, R. and Harter, J. et al. Inactivation and purification of HIV-1 as antigen for the treatment of HIV-1 infection. Biopharm. 1996, 9, 22-34.
3. 3 Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
4. 4 Towbin, H., Staehelin, T. and Gordon, L. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. U.S.A. 1979, 76, 4350-4354.
5. 5 Beeley, J.G. Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 16. Glycoprotein and proteoglycan techniques. Elsevier Science, Amsterdam, 1985.
6. 6 Hounsell, E.F. Glycoprotein Analysis in Biomedicine, Vol. 14. Methods in molecular biology. Humana Press, Totowa, NJ, 1993.
7. 7 Aloia R.C. and Mlekusch G. Quantitative analysis of membrane lipid components. In Advances in Membrane Fluidity (Eds Aloia R.C., Curtain C.C. and Gordon L.M.). Alan R. Liss, New York, 1989.
8. 8 Aloia, R.C., Jensen, F.C. and Curtain, C.C. et al. Lipid composition and fluidity of the Human Immunodeficiency Virus. Proc. Natl Acad. Sci. U.S.A. 1988, 85, 900-904.
9. 9 Aloia, R.C., Tian, H, and Jensen, F.C. Lipid composition and fluidity of the Human Immunodeficiency Virus envelope and host plasma membranes. Proć. Natl. Acad. Sci. U.S.A. 1993, 90, 5181 5185.
10. 10 Ferre, F., Pezzoli, P., Buxton, E., et al. Quantification of RNA targets using the Polymerase chain reaction. In Molecular Methods for Virus Detection (Eds Wiedbrauk, D. and Farkas, D.H.), Academic Press, Inc., San Diego, CA, 1995, pp. 193 218.
11. 11 Ferre, F., Marchese, A., Pezzoli, P., Griffin, S., Buxton, E., and Boyer, V. Quantitative PCR: an overview. In The Polymerase Chain Reaction (Eds Mullis, K.B., Ferre, F. and Gibbs, R.). Birkhauser, Cambridge, MA, 1994, pp. 67-88.
12. 12 Fischer, L. Gel Filtration Chromatography. Laboratory Techniques in Biochemistry and Molecular Biology (Eds Work, T.S. and Burdon, R.H.), 2nd revision. Elsevier, Amsterdam, 1986.
13. 13 Gelderblom, H.R. Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 1991, 5, 617-637.
14. 14 Henderson, L.E., Bowers, M.A. and Sowder II, R.C. II et al. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 1992, 66, 1856-1865.
15. 15 Henderson, L.E., Copeland, T.D., Sowder, R.C., et al. Analysis of proteins and peptides purified from sucrose gradient banded HTLV-III. Human Retroviruses, Cancer, and AIDS: Approaches to Prevention and Therapy. Alan R. Liss, Inc. New York, NY. 1988, pp. 134-147.
16. 16 Levy, J.A, Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 1993, 57, 183-289.
17. 17 Arthur, L.O., Bess, J. Jr and Sowder, R.C. Jr et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992, 258, 1935-1938.
18. 18 Bourinbaiar, A.S., Nagortny, T. and Tan, X. Heaviness of HIV particles in quantum relation to viral intectiousness and responsiveness to Interferon. In Viral Quantificationtalion in HIV Infection (Ed. Andrieu, J-M. and Libby, J.). Eurotest, Paris, 1991, pp. 41-52.
19. 19 Mathews, R.E.F. Fourth report of the international committee on taxonomy of viruses. Classification and nomenclature of viruses. Intervirology 1982, 17, 1-199.
20. 20 Paxton, W., Connor, R.I. and Landau, N.R. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of GAG and mutational analysis. J. Virol. 1993, 67, 7229-7237.
21. 21 Lui, H., Wu, X. and Newman, M. et al. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 1995, 69, 7630-7638.
22. 22 Trono, D. HIV accessory proteins: leading roles for supporting cast. Cell 1995, 82, 189-192.
23. 23 Golding, H., Shearer, G.M. and Hillman, K. et al. Common epitope in human immunodeficiency virus (HIV) 1-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV 1-infected individuals. J. Clin. Invest. 1989, 83, 1430-1435.
24. 24 Colgan, J., Yuan, H. and Franke, K.E. et al. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J. Virol. 1996, 707, 4299-4310.
25. 25 Huyghe, G.B., Liu, X. and Sutjipto, S. et al. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Human Gene Ther. 1995, 6, 1403-1416.
26. TM) on β chemokine and cytokine production in subjects with HIV-1 infection. J. AIDS Human Retrovirol. 1997, 14, 343-350.